HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shampa Chatterjee Selected Research

Cromakalim (Levcromakalim)

1/2012Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS.
12/2005Activation of endothelial NADPH oxidase during normoxic lung ischemia is KATP channel dependent.
4/2004Endothelial cell proliferation associated with abrupt reduction in shear stress is dependent on reactive oxygen species.
10/2003Shear stress increases expression of a KATP channel in rat and bovine pulmonary vascular endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shampa Chatterjee Research Topics

Disease

17Inflammation (Inflammations)
02/2022 - 05/2010
16Ischemia
10/2019 - 10/2003
9Lung Injury
10/2021 - 01/2009
8Acute Lung Injury
10/2021 - 05/2010
7Pneumonia (Pneumonitis)
09/2021 - 05/2013
4Neoplasms (Cancer)
03/2018 - 05/2010
3COVID-19
02/2022 - 03/2021
3Edema (Dropsy)
06/2021 - 01/2015
3Hyperoxia
04/2016 - 01/2015
2Bacterial Infections (Bacterial Infection)
10/2021 - 01/2020
2Infections
03/2021 - 01/2018
2Primary Graft Dysfunction
01/2019 - 04/2016
2Reperfusion Injury
01/2017 - 02/2008
2Body Weight (Weight, Body)
01/2015 - 05/2013
2Fibrosis (Cirrhosis)
05/2010 - 01/2009
1Sepsis (Septicemia)
10/2021
1Ventilator-Induced Lung Injury
06/2021
1Hypoxia (Hypoxemia)
11/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Hyperemia
10/2019
1Lung Diseases (Lung Disease)
11/2018
1Stroke (Strokes)
11/2018
1Pulmonary Atelectasis
01/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2015
1Pulmonary Embolism
11/2014
1Pulmonary Edema
04/2014

Drug/Important Bio-Agent (IBA)

13Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 04/2004
10NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020 - 01/2005
8Proteins (Proteins, Gene)FDA Link
06/2021 - 05/2010
8Adenosine Triphosphate (ATP)IBA
02/2014 - 10/2003
4InflammasomesIBA
02/2022 - 01/2017
4Peroxiredoxin VIIBA
10/2021 - 01/2015
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2009
4Cromakalim (Levcromakalim)IBA
01/2012 - 10/2003
3NADPH Oxidase 2IBA
10/2021 - 02/2014
3Peptides (Polypeptides)IBA
06/2021 - 05/2019
3Phospholipases A2 (Phospholipase A2)IBA
06/2021 - 01/2015
3Thiobarbituric Acid Reactive SubstancesIBA
06/2021 - 04/2008
3AerosolsIBA
01/2021 - 01/2019
31- hexadecyl- 3- trifluoroethylglycero- sn- 2- phosphomethanolIBA
01/2015 - 05/2013
3KATP ChannelsIBA
06/2013 - 10/2003
2Caspase 1 (ICE Protease)IBA
02/2022 - 09/2021
2Hydrochloric Acid (Hydrogen Chloride)FDA Link
10/2021 - 11/2020
2Peroxidase (Myeloperoxidase)IBA
08/2021 - 01/2018
2Pyruvic Acid (Pyruvate)IBA
11/2020 - 01/2018
2Lactic Acid (Lactate)FDA LinkGeneric
11/2020 - 01/2018
2Biological ProductsIBA
01/2020 - 01/2020
2LipopolysaccharidesIBA
01/2020 - 05/2019
2Oxygen (Dioxygen)IBA
10/2019 - 04/2016
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2019 - 01/2018
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 11/2014
2AsbestosIBA
03/2018 - 01/2017
2LGM2605IBA
11/2017 - 01/2017
2CytokinesIBA
01/2017 - 04/2014
2Nitric Oxide Synthase (NO Synthase)IBA
11/2014 - 01/2008
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2014 - 02/2014
2WortmanninIBA
01/2012 - 04/2008
2AntioxidantsIBA
05/2010 - 02/2008
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
04/2008 - 12/2005
2hydroethidineIBA
04/2008 - 12/2005
22',7'-dichlorodihydrofluoresceinIBA
04/2008 - 12/2005
2diphenyleneiodoniumIBA
12/2005 - 04/2004
2FlavoproteinsIBA
12/2005 - 04/2004
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1Amino AcidsFDA Link
06/2021
1salicylhydroxamic acid (SHAM)IBA
11/2020
1Phenobarbital (Luminal)FDA Link
10/2019
1NicotineFDA Link
01/2019
1Cell Adhesion MoleculesIBA
01/2019
1C-Reactive ProteinIBA
01/2019
1Pharmaceutical PreparationsIBA
11/2018
1EndotoxinsIBA
01/2018
1Oxidants (Oxidizing Agents)IBA
01/2018
1Protons (Proton)IBA
11/2017
1Reactive Nitrogen SpeciesIBA
01/2017
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2017
1Chemokine CXCL12IBA
01/2017
1VildagliptinIBA
01/2017
1Prostaglandins DIBA
04/2016
1SmokeIBA
04/2016
1tert-ButylhydroperoxideIBA
10/2015
1Surface-Active Agents (Surfactants)IBA
01/2015
1Codon (Codons)IBA
01/2015
1Isoleucine (L-Isoleucine)FDA Link
01/2015
1Protein CIBA
01/2015
1Threonine (L-Threonine)FDA Link
01/2015
1IsoprostanesIBA
04/2014
1fluorescein isothiocyanate dextranIBA
04/2014
1Chemokine CXCL2IBA
04/2014
1ChemokinesIBA
04/2014
1LipidsIBA
05/2013

Therapy/Procedure

6Artificial Respiration (Mechanical Ventilation)
02/2022 - 01/2018
2Ligation
10/2021 - 02/2014
2Radiotherapy
11/2017 - 05/2010
2Lung Transplantation
04/2016 - 11/2014
1Punctures
10/2021
1Length of Stay
01/2019
1Intraperitoneal Injections
01/2015
1Quantum Dots (Quantum Dot)
02/2014